Volume 1, Issue 3

2014pp 183—247

About the Cover

Immunofluorescence from antibodies for FLAG and EFEMP1 for ectopic EFEMP1 carrying an N-terminal FLAG tag and endogenous/ectopic EFEMP1. See Hu et al.

Editorials

Sirtainties in pancreatic cancer?

Ilse Rooman

https://doi.org/10.18632/oncoscience.28pp 183—184

PDF Full-Text

Research Papers

Integrin alphaV modulates the cellular pharmacology of copper and cisplatin by regulating expression of the influx transporter CTR1

Xinjian Lin, Xiying Shang, Gerald Manorek, Mariama Fofana, Stephen B. Howell

https://doi.org/10.18632/oncoscience.22pp 185—195

View Abstract PDF Full-Text

HER2 and HER3 cooperatively regulate cancer cell growth and determine sensitivity to the novel investigational EGFR/HER2 kinase inhibitor TAK-285

Shinji Takagi, Hiroshi Banno, Akira Hayashi, Toshiya Tamura, Tomoyasu Ishikawa, Yoshikazu Ohta

https://doi.org/10.18632/oncoscience.23pp 196—204

View Abstract PDF Full-Text

Anti-EGFR function of EFEMP1 in glioma cells and patient prognosis

Yuanjie Hu, Hengjun Gao, Christopher Vo, Chao Ke, Francine Pan, Liping Yu, Eric Siegel, Kenneth R Hess, Mark E. Linskey, Yi-Hong Zhou

https://doi.org/10.18632/oncoscience.24pp 205—215

View Abstract PDF Full-Text

Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor

Georgia A. McCann, Shan Naidu, Kellie S. Rath, Hemant K. Bid, Brent J. Tierney, Adrian Suarez, Saradhadevi Varadharaj, Jianying Zhang, Kalman Hideg, Peter Houghton, Periannan Kuppusamy, David E. Cohn, Karuppaiyah Selvendiran

https://doi.org/10.18632/oncoscience.26pp 216—228

View Abstract PDF Full-Text